Share this post:

Petra Grijzen of BNR’s Spitsuur interviews Marijn Verhoef of the Access to Medicine Foundation about the AMR Benchmark. Marijn discusses the key findings of the Benchmark and explains how a company like GSK sets a good example for tracking resistant bacteria in countries where they sell products.

Listen Live